Skip to content

Effects of lavender essential oil inhalation on pain in patients with postherpetic neuralgia

Effects of lavender essential oil inhalation on intensity and quality of pain in patients with postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007772
Enrollment
64
Registered
2022-10-06
Start date
2013-04-14
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Inhalation of essential oil) : Participants were randomly allocated to the control and three experimental groups. In the experimental groups, 1 ml of 1% lavender essential oil, 1% linalool or 1

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Participants with VAS pain scores of 4 or greater 2) Participants who did not receive neurological treatment for herpes zoster 3) Participants who is conscious and able to communicate and have orientation 4) Participants with no olfactory dysfunction and no allergic reaction to the aroma 5) Participants who are not taking medications due to psychiatric illness 6) Participants who are not receiving hormone and aromatherapy

Exclusion criteria

Exclusion criteria: 1) Participants with VAS pain scores of less than 4 2) Participants who received neurological treatment for herpes zoster 3) Participants who is unconscious or not able to communicate or do not have orientation 4) Participants with olfactory dysfunction or allergic reaction to the aroma 5) Participants who are taking medications due to psychiatric illness 6) Participants who are receiving hormone and aromatherapy

Design outcomes

Primary

MeasureTime frame
quality of pain;degree of pain;intensity of pain

Countries

Korea, Republic of

Contacts

Public Contactjiyeong You

Korea University Ansan Hospital

youjy0402@korea.ac.kr+82-31-412-5114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 9, 2026